January 06, 2025

Risk-Reducing Surgeries Improve Survival for Younger Patients With Breast Cancer Who Are BRCA Carriers, Study Finds

Patients with early-onset breast cancer (aged 40 or younger at diagnosis) who have BRCA1 and/or BRCA2 pathogenic or likely pathogenic variants had improved overall survival by undergoing risk-reducing...

The ASCO Post

December 23, 2024

Combination of Two Oral Agents May Improve Progression-Free Survival in Patients With Previously Untreated CLL

The ASCO Post

January 06, 2025

RELATIVITY-047: Extended Analysis of Overall Survival With Nivolumab/Relatlimab vs Nivolumab in Previously Untreated Advanced Melanoma

The ASCO Post

December 16, 2024

Negative Colonoscopy Screening Results and Risk for Colorectal Cancer and Mortality

The ASCO Post

January 06, 2025

Advanced Imaging May Uncover Hidden Metastases in High-Risk Prostate Cancer Cases

The ASCO Post

December 04, 2024

Lenvatinib/Pembrolizumab vs Chemotherapy in Advanced Endometrial Cancer

The ASCO Post

Latest Headlines

January 17, 2025

Risks of Preterm Birth, Low Birth Weight, Birth Defects Among Children Born to Young Men With Cancer

The ASCO Post

January 17, 2025

FDA Approves Datopotamab Deruxtecan-dlnk for Advanced HR-Positive, HER2-Negative Breast Cancer

The ASCO Post

January 17, 2025

Fulvestrant vs Anastrozole in Endocrine Therapy–Naive, HR-Positive, HER2-Negative Advanced Breast Cancer

The ASCO Post

January 17, 2025

FDA Approves Acalabrutinib With Bendamustine and Rituximab for Previously Untreated Mantle Cell Lymphoma

The ASCO Post

January 17, 2025

FDA Approves Sotorasib With Panitumumab for KRAS G12C–Mutated Colorectal Cancer

The ASCO Post

January 17, 2025

AACR Expresses Sincere Appreciation After NIH Director Monica M. Bertagnolli, MD, Steps Down

The ASCO Post

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

Conference Coverage

All Conference News View Conference Calendar

ESMO Congress 2024

January 14, 2025

ADRIATIC Trial: Durvalumab Consolidation Extends Survival in Limited-Stage Small Cell Lung Cancer

The ASCO Post

September 20, 2024

Phase III CABINET Trial: Cabozantinib in Advanced Neuroendocrine Tumors

The ASCO Post

December 09, 2024

Adding Chemoradiation in Perioperative Gastric Cancer Treatment Improves Pathologic Response Rates Without Survival Benefit

The ASCO Post

2024 SABCS

January 10, 2025

Adjuvant Tamoxifen Reduces 15-Year Risk of Recurrence in ‘Good Risk’ DCIS Without Radiation Therapy

The ASCO Post

January 08, 2025

OlympiA Trial: Long-Term Benefits of Olaparib Confirmed in High-Risk Subgroup of Breast Cancer

The ASCO Post

January 07, 2025

Addition of Palbociclib to Standard Therapy in Metastatic Hormone Receptor–Positive, HER2-Positive Breast Cancer

The ASCO Post

2024 SITC Annual Meeting

January 07, 2025

Novel Combination Studied in HPV16-Positive Relapsed or Metastatic Head and Neck Squamous Cell Carcinoma

The ASCO Post

December 09, 2024

Updated Findings in Preventive Breast Cancer Vaccine Study

The ASCO Post

December 05, 2024

SITC: Study Finds IO102-IO103 Vaccine Plus Pembrolizumab Active in Patients With Non–Small Cell Lung Cancer

The ASCO Post

Clinical Guidelines

January 17, 2025

FDA Approves Acalabrutinib With Bendamustine and Rituximab for Previously Untreated Mantle Cell Lymphoma

The ASCO Post

January 07, 2025

Addition of Palbociclib to Standard Therapy in Metastatic Hormone Receptor–Positive, HER2-Positive Breast Cancer

The ASCO Post

January 06, 2025

Risk-Reducing Surgeries Improve Survival for Younger Patients With Breast Cancer Who Are BRCA Carriers, Study Finds

The ASCO Post

December 23, 2024

FDA Grants Accelerated Approval to Encorafenib Combination for BRAF V600E–Mutant Metastatic Colorectal Cancer

The ASCO Post

Commentary & Perspectives

July 10, 2023

Expert Point of View: Pamela L. Kunz, MD and Corrie Marijnen, MD, PhD

The ASCO Post

January 25, 2023

Communicating Prognosis: A Core Competency of Patient-Centered Oncology Care

The ASCO Post

June 09, 2023

Rethinking Prior Authorization

The ASCO Post

October 25, 2023

Gender Equity in Academic Hematology: Where There’s a ‘WiL,’ There’s a Way

The ASCO Post

FDA & Government News

January 17, 2025

FDA Approves Datopotamab Deruxtecan-dlnk for Advanced HR-Positive, HER2-Negative Breast Cancer

The ASCO Post

January 17, 2025

FDA Approves Sotorasib With Panitumumab for KRAS G12C–Mutated Colorectal Cancer

The ASCO Post

January 03, 2025

Surgeon General Issues Advisory on Alcohol, Cancer Link

Conexiant

July 18, 2023

First Oral Medication to Treat Moderate-to-Severe Crohn’s Disease Earns FDA Approval

Mount Sinai New York

Business Management

April 01, 2023

Change is Constant

Inside Dental Hygiene

February 08, 2023

Machine Learning and the Power to Outsmart Cancer

Cedars-Sinai Pulse

June 10, 2024

How the Museum of Medicine and Biomedical Discovery Aims to Bring Scientific Achievements of the Past, Present, and Future to Life

The ASCO Post

March 01, 2023

Exceeding Patient Expectations With Bioceramic Cements and More

Inside Dentistry

Trending Now

Trending Now

Find topic & conditions by first letter

Compendium

Inside Dental Hygiene

Inside Dental Technology

Inside Dentistry

Special Issues

The ASCO Post

JADPRO

JNCCN

JNCCN 360

Corneal Physician

Glaucoma Physician

New Retinal Physician

Ophthalmology Management

Ophthalmic Professional

Presbyopia Physician

Retinal Physician

Contact Lens Spectrum

Eyecare Business

Optometric Management

Presbyopia Physician

Negative Colonoscopy Screening Results and Risk for Colorectal Cancer and Mortality

Advanced Imaging May Uncover Hidden Metastases in High-Risk Prostate Cancer Cases

Lenvatinib/Pembrolizumab vs Chemotherapy in Advanced Endometrial Cancer

Latest Headlines

Daily News

Recommendations

Featured Videos

Conference Coverage

ESMO Congress 2024

2024 SABCS

2024 SITC Annual Meeting

Clinical Guidelines

Commentary & Perspectives

FDA & Government News

Business Management